In response to the NIH Program Announcement PAR-13-279, Charles R. Drew University of Medicine and Science (CDU) proposes to continue and expand the success of the Accelerating excellence In Science (AXIS) program. AXIS is the integrated "home" for clinical and translational research. AXIS houses experienced leadership as well as a myriad of clinical, translational, community-partnered activities, well matched by the education, training, and technology resources and excellent research core services. In the first five years, AXIS has laid the foundation at CDU to establish itself as the central hub of translational research. In the next five years, CDU will continue building on this progress and further develop its focus as the main research infrastructure program that will promote multi- and interdisciplinary collaborations between CDU investigators and community partners targeting health disparities. The vision of the University Research Enterprise is to be a leading player in the national effort to eliminate health disparities, specifically through AXIS in three areas of focus which disproportionally affect Service Planning Area 6: Cancer, Cardiometabolic Disease (CMD), and HIV/AIDS. AXIS proposes three programmatic goals that align with the vision of the University's Research Enterprise: " Goal 1: To enhance the infrastructure capacity in translational research in the areas of Cancer, Cardiometabolic, and HIV/AIDS. Although other areas of research at CDU will also be served, the focus will be to create expertise and research success in these three areas.
This aim will also ensure that CDU continues to provide national leadership in reducing health disparities by increasing the quality and quantity of researchers from minority and underserved populations conducting disparities research. "Goal 2: To integrate basic, clinical, and community-partnered translational research by fostering collaboration among disciplines, departments and schools at CDU, and collaboration with community leaders and investigators across other research institutions." Goal 3: To facilitate professional development and best practices in mentored clinical and translational research training on minority health and health disparities. "To reach these goals, the AXIS Center will include 8 Cores that will offer services, resources, and training for all research conducted at CDU: 1 .Administrative Core, 2.Collaborations and Partnerships, and Community Core, 3.Professional Development and Pilots Core, 4. Evaluation Core, 5.Biomedical Informatics Core, 6.Research Design and Biostatistics Core, 7.Clinical Research Resources and Facilities Core, 8. Technology and Laboratory Core.

Public Health Relevance

Development of a robust infrastructure for clinical and translational research to address high priority disease areas of cancer, cardiometabolic disorders, and HIV/AIDs will significantly impact health disparities among underserved and ethnic/racial minority populations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54MD007598-06
Application #
8807130
Study Section
Special Emphasis Panel (ZMD1-RN (03))
Program Officer
Mcclure, Shelia A
Project Start
2009-09-28
Project End
2019-04-30
Budget Start
2014-07-10
Budget End
2015-04-30
Support Year
6
Fiscal Year
2014
Total Cost
$2,714,715
Indirect Cost
$919,945
Name
Charles R. Drew University of Medicine & Science
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Wang, Piwen; Phan, Tien; Gordon, David et al. (2015) Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells. Mol Nutr Food Res 59:250-61
Garcia, Leah A; Hlaing, Su M; Gutierrez, Richard A et al. (2014) Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage. Int J Mol Sci 15:17204-20
Davidson, Mayer B (2014) Insulin analogs--is there a compelling case to use them? No! Diabetes Care 37:1771-4
Davidson, Mayer B; Duran, Petra; Lee, Martin L (2014) Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethn Dis 24:195-9
Davidson, Mayer B; Pan, Deyu (2014) Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications 28:464-9
Wu, Yanyuan; Kim, Juri; Elshimali, Yayha et al. (2014) Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice. BMC Cancer 14:266
Tan, Gemma; Elefanty, Andrew G; Stanley, Edouard G (2014) *-cell regeneration and differentiation: how close are we to the 'holy grail'? J Mol Endocrinol 53:R119-29
Del Pino, Homero E; Moore, Mignon R; McCuller, William J et al. (2014) Negotiating Emotional Support: Sober Gay Latinos and their Families. J Gay Lesbian Soc Serv 26:222-243
Davidson, Mayer B (2014) Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement. Diabetes Care 37:3-4
Bazargan-Hejazi, Shahrzad; Kim, Eunjin; Lin, Johnny et al. (2014) Risk factors associated with different types of intimate partner violence (IPV): an emergency department study. J Emerg Med 47:710-20

Showing the most recent 10 out of 53 publications